Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer
Directed Therapy
|
Dana-Farber Cancer Institute / Andrew Hong, MD |
Young Investigator Grants |
2015 |
Massachusetts |
Targeting the Rac GTPase Pathway to Sabotage RAS Signaling in RAS-mutated Leukemia |
Boston Children’s Hospital / Sara Canovas Nunes, PhD |
Young Investigator Grants |
2020 |
Massachusetts |
Olfactory Ensheathing Cells for Pediatric Glioma Gene/Cell Therapy |
Massachusetts General Hospital / Bakhos Tannous, PhD |
Innovation Grants |
2018 |
Massachusetts |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Development of RADARS-based Therapy to Treat Fusion Molecule Driven Pediatric Malignancies |
Boston Children’s Hospital / Alan B. Cantor, MD, PhD |
Innovation Grants |
2023 |
Massachusetts |
Role of LMO1 in Neuroblastoma Initiation and Maintenance: Analysis in the Zebrafish model of Childhood Neuroblastoma |
Dana-Farber Cancer Institute / Thomas Look, M.D. |
Innovation Grants |
2014 |
Massachusetts |
Epigenetic regulation of genomic instability and its therapeutic implications in T-cell acute lymphoblastic leukemia |
Dana-Farber Cancer Institute / Birgit Knoechel, MD/PhD |
Innovation Grants |
2019 |
Massachusetts |
Investigating the Role of the RNA Binding Protein LIN28 in Neuroblastoma |
Boston Children’s Hospital / John Powers |
Young Investigator Grants |
2012 |
Massachusetts |
The Role of Prmt1 in Osteosarcoma Initiation and Metastasis |
Dana-Farber Cancer Institute / Hao-Ru Hsu, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
Investigating the Role of Lin-28 in Germ Cell Tumorigenesis |
Boston Children’s Hospital / George Daley, MD/PhD |
Innovation Grants |
2011 |
Massachusetts |